Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (ChiCTR2600133408) titled 'Efficacy and Safety of Human Embryonic Stem Cell Derived Mesenchymal Stromal Cells for Acute Graft-versus-Host Disease in Children' on Sept. 26.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Children's Hospital, Capital Medical University
Condition:
Pediatric Acute Graft-versus-Host Disease
Intervention:
Experimental group:Conventional treatment combined with ZH901 cell injection, 1x10^6 cells/kg, administered on day1, day4, day8, day11, day15, and day22, for a total of 6 times.
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-10-31
Targe...